Kurzfassung

Nasal high flow therapy (NHF) is a promising method for tailored, less invasive long-term ventilatory support for preterm infants. If ventilatory support with NHF is similarly effective to conventional nasal continuous positive airway pressure (NCPAP), clinicians are likely to adopt this method for widespread clinical use because of its improved comfort and potential other benefits. Primary aim of this trial is to examine cardiorespiratory stability in preterm infants treated with two...Nasal high flow therapy (NHF) is a promising method for tailored, less invasive long-term ventilatory support for preterm infants. If ventilatory support with NHF is similarly effective to conventional nasal continuous positive airway pressure (NCPAP), clinicians are likely to adopt this method for widespread clinical use because of its improved comfort and potential other benefits. Primary aim of this trial is to examine cardiorespiratory stability in preterm infants treated with two commonly used nasal high flowrates in comparison to NCPAP. Secondary aim is to examine potential comfort-related beneficial effects of NHF.Nasal high flow therapy (NHF) is a promising method for tailored, less invasive long-term ventilatory support for preterm infants. If ventilatory support with NHF is similarly effective to conventional nasal continuous positive airway pressure (NCPAP), clinicians are likely to adopt this method for widespread clinical use because of its improved comfort and potential other benefits. Primary aim of this trial is to examine cardiorespiratory stability in preterm infants treated with two commonly used nasal high flowrates in comparison to NCPAP. Secondary aim is to examine potential comfort-related beneficial effects of NHF.» weiterlesen» einklappen